Article info

Download PDFPDF
Nucleosome accumulation and reduction of C-reactive protein are associated with the generation of anti-nuclear antibodies in patients with rheumatoid arthritis treated with adalimumab, but not with etanercept
  1. Correspondence to Professor G Valesini, Dipartimento di Clinica e Terapia Medica, Reumatologia, “Sapienza” Università di Roma, Viale del Policlinico 155, 00161 Roma, Italy; guido.valesini{at}uniroma1.it
View Full Text

Citation

Priori R, Alessandri C, Magrini L, et al
Nucleosome accumulation and reduction of C-reactive protein are associated with the generation of anti-nuclear antibodies in patients with rheumatoid arthritis treated with adalimumab, but not with etanercept

Publication history

  • Accepted November 13, 2008
  • First published August 12, 2009.
Online issue publication 
August 12, 2009

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.